Navigation and service

You are here:Rote-Hand-Briefe and Information Letters

Information Letter on Palexia® 20 mg/ml oral solution (tapentadol): Administration to children and adolescents in hospitals

Date 2018.12.06
Active substance tapentadol

The company Grünenthal is circulating information on a new dosing pipette for weight-based dosing in children with a body weight of more than 16 kg.